Exploring the potential of TCX-101, an antibody targeting a tumor-associated carbohydrate antigen, as a bispecific T cell engager for the treatment of solid tumors

被引：0
|
作者：
Winkler, W. [1 ]
Moreira, G. Marcal Schmidt Garcia [2 ]
Muraca, F. [1 ]
Gomes, F. Gueths [1 ]
Sondermann, P. [3 ]
Ocker, M. [4 ]
机构：
[1] Tacalyx GmbH, Cell Biol, Berlin, Germany
[2] Tacalyx GmbH, Antibody & Prot Biochem, Berlin, Germany
[3] Tacalyx GmbH, Berlin, Germany
[4] Tacalyx GmbH, Expt Med, Berlin, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 211卷
关键词：
D O I：
10.1016/j.ejca.2024.114970
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PB451
引用
收藏
页码：S171 / S172
页数：2
相关论文
共 50 条
  • [41] HLA-G-TCB (RG6353), a T cell bispecific antibody for the treatment of solid tumors in monotherapy and combination with immunomodulator agents
    Majety, Meher
    Hage, Carina
    Bujotzek, Alexander
    Schneider, Anneliese
    Lechmann, Martin
    Nair, Nitya
    Zimmerman, Stefan
    Morel, Anthony
    Klein, Christian
    Umana, Pablo
    CANCER RESEARCH, 2023, 83 (07)
  • [42] CEA TCB: A novel head-to-tail 2:1 T cell bispecific antibody for treatment of CEA-positive solid tumors
    Bacac, Marina
    Klein, Christian
    Umana, Pablo
    ONCOIMMUNOLOGY, 2016, 5 (08):
  • [43] Targeting the tumor-associated carbohydrate antigen STn with humanized anti-Sialyl-Tn monoclonal antibody-drug conjugates inhibits ovarian cancer tumor growth in vitro and in vivo.
    Dransfield, Daniel T.
    Prendergast, Jillian M.
    Eavarone, David A.
    Nazer, Rawan
    Al-Alem, Linah
    Stein, Jenna
    Behrens, Jeff
    Rueda, Bo
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 95 - 96
  • [44] Pharmacokinetics (PK) and pharmacodynamics (PD) of a novel carcinoembryonic antigen (CEA) T-cell bispecific antibody (CEA-CD3 TCB) for the treatment of CEA-positive solid tumors
    Melero, I.
    Segal, N. H.
    Saro, J.
    Ros, W.
    Martinez-Garcia, M.
    Argiles, G.
    Moreno, V.
    Ponce, S.
    Marabelle, A.
    Cleary, J. M.
    Hurwitz, H. I.
    Eder, J. P.
    Jamois, C.
    Andersson, E.
    Bouseida, S.
    Sandoval, F.
    Bacac, M.
    Nayak, T.
    Karanikas, V.
    Calvo, E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [45] A phase I study evaluating DLYE5953A, an antibody-drug conjugate targeting the tumor-associated antigen lymphocyte antigen 6 complex locus E (Ly6E), in patients (Pts) with solid tumors
    Modi, S.
    Eder, J. P.
    Lorusso, P.
    Weekes, C.
    Chandarlapaty, S.
    Tolaney, S. M.
    McLaughlin, J.
    Camidge, D. R.
    Chang, C-W.
    Nazzal, D.
    Chen, S-C.
    Schuth, E.
    Brunstein, F.
    Darbonne, W.
    Flanagan, W.
    Ungewickell, A.
    Shapiro, G.
    ANNALS OF ONCOLOGY, 2016, 27
  • [46] Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1
    Ding, Chuanlin
    Wang, Li
    Marroquin, Jose
    Yan, Jun
    BLOOD, 2008, 112 (07) : 2817 - 2825
  • [47] Targeting the tumor and its associated stroma: One and one can make three in adoptive T cell therapy of solid tumors
    Mondino, Anna
    Vella, Gerlanda
    Icardi, Laura
    CYTOKINE & GROWTH FACTOR REVIEWS, 2017, 36 : 57 - 65
  • [48] EGFRvIII-Targeting DNA-Encoded Immune Cell Engager (DICE) Generates In Vivo Expression of Bispecific Antibody that Induces T Cell-Mediated Cytolytic Activities Against EGFRvIII-Positive Tumors and Controls Tumor Growth in a GBM Mouse Model
    Park, Daniel H.
    Perales-Puchalt, Alfredo
    Bhojnagarwala, Pratik
    Gary, Ebony N.
    Zhu, Xizhou
    Patel, Ami
    Yun, Kun
    Smith, Trevor
    Muthumani, Kar
    Weiner, David B.
    MOLECULAR THERAPY, 2020, 28 (04) : 497 - 497
  • [49] SELECTIVE LOSS OF EXPRESSION OF A TUMOR-ASSOCIATED ANTIGEN ON A HUMAN-LEUKEMIA CELL-LINE INDUCED BY TREATMENT WITH MONOCLONAL-ANTIBODY AND COMPLEMENT
    GEE, AP
    BRUCE, KM
    VANHILTEN, J
    SIDEN, EJ
    BRAYLAN, RC
    BAUER, PC
    BOYLE, MDP
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1987, 78 (01): : 29 - 35
  • [50] Pharmacokinetics (PK) and pharmacodynamics (PD) of a novel carcinoembryonic antigen (CEA) T-cell bispecific antibody (CEA CD3 TCB) for the treatment of CEA-expressing solid tumors.
    Melero, Ignacio
    Segal, Neil Howard
    Suarez, Jose M. Saro
    Ros, Willeke
    Garcia, Maria Martinez
    Calvo, Emiliano
    Moreno, Victor
    Aix, Santiago Ponce
    Marabelle, Aurelien
    Cleary, James M.
    Hurwitz, Herbert
    Eder, Joseph Paul
    Jamois, Cancize
    Belousov, Anton
    Bouseida, Said
    Sandoval, Federico
    Bacac, Marina
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345